Keywords: Parkinson's Disease, Multimodal, Atlas, Subcortex
MRI holds great promise to unravel the selective vulnerability and functional differentiation of the nigrosomes in the human substantia nigra pars compacta. Based on block-face imaging and calbindin-D28K immunohistochemistry, we constructed a 3D nigrosome atlas. Using this atlas, we demonstrate several nigrosomes to show increased R2* values in post mortem tissue. Our results further challenge the common identification of the nigrosomes with hyperintense structures in in vivo MRI, particularly nigrosome 1 and the swallow tail sign.
We thank the whole-body donation program at the University of Maastricht for providing post mortem brain samples.13
The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013) / ERC grant agreement n° 616905. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 681094 and is supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0137. This project has also received funding from the BMBF (01EW1711A & B) in the framework of ERA-NET NEURON. This research was financially supported by STW/NWO, NWO VICI, the European Research Council (no. 616905), Brain Foundation of the Netherlands, and Stichting Internationaal Parkinson Fonds. The research leading to parts of these results has received funding from the DFG, PP 2041 Computational Connectomics (MO 2249/3-1, MO 2249/3-2 and KI 1337/2-2), and the Alzheimer Forschung Initiative (AFI#18072) to M.M.
M. Brammerloh has received funding from the International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity.
1. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain. 1999;122(8):1421-1436. doi:10.1093/brain/122.8.1421
2. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain J Neurol. 1999;122(8):1437-1448.
3. Haber SN, Knutson B. The Reward Circuit: Linking Primate Anatomy and Human Imaging. Neuropsychopharmacology. 2010;35(1):4-26. doi:10.1038/npp.2009.129
4. Lehericy S, Vaillancourt DE, Seppi K, et al. The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward. Mov Disord. 2017;32(4):510-525. doi:10.1002/mds.26968
5. Brammerloh M, Morawski M, Friedrich I, et al. Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry. NeuroImage. 2021;239:118255. doi:10.1016/j.neuroimage.2021.118255
6. Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. NeuroReport. 2006;17(11):1215-1218. doi:10.1097/01.wnr.0000227984.84927.a7
7. Gaurav R, Yahia‐Cherif L, Pyatigorskaya N, et al. Longitudinal Changes in Neuromelanin MRI Signal in Parkinson’s Disease: A Progression Marker. Mov Disord. n/a(n/a). doi:https://doi.org/10.1002/mds.28531
8. Schwarz ST, Mougin O, Xing Y, et al. Parkinson’s disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI. NeuroImage Clin. 2018;19:683-689. doi:10.1016/j.nicl.2018.05.027
9. Cassidy CM, Zucca FA, Girgis RR, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci. 2019;116(11):5108-5117. doi:10.1073/pnas.1807983116
10. Brammerloh M, Kirilina E, Alkemade A, et al. Swallow Tail Sign: Revisited. Radiology. Published online August 16, 2022:212696. doi:10.1148/radiol.212696
11. Rua C, O’Callaghan C, Ye R, et al. Substantia nigra ferric overload and neuromelanin loss in Parkinson’s disease measured with 7T MRI. Published online April 20, 2021:2021.04.13.21255416. doi:10.1101/2021.04.13.21255416
12. Bazin PL, Alkemade A, Mulder MJ, Henry AG, Forstmann BU. Multi-contrast anatomical subcortical structures parcellation. Verstynen T, Frank MJ, Verstynen T, Neumann WJ, eds. eLife. 2020;9:e59430. doi:10.7554/eLife.59430
13. Alkemade A, Bazin PL, Balesar R, et al. A unified 3D map of microscopic architecture and MRI of the human brain. Sci Adv. 2022;8(17):eabj7892. doi:10.1126/sciadv.abj7892
14. Massey L, Miranda M, Al-Helli O, et al. 9.4T MR microscopy of the substantia nigra with pathological validation in controls and disease. NeuroImage Clin. 2017;13:154-163. doi:10.1016/j.nicl.2016.11.015
15. Di Lorenzo Alho AT, Suemoto CK, Polichiso L, et al. Three-Dimensional and Stereological Characterization of the Human Substantia Nigra During Aging. Brain Struct Funct. 2016;221(7):3393-3403. doi:10.1007/s00429-015-1108-6
Fig 2: Volumes of the nigrosomes in our atlas follow the dopaminergic neuron (DN) count by Damier et al.1 The y-axis shows the nigrosome volume in MRI space for each brain (one marker shape and gray line per brain). The error bars show the standard error of the mean DN count. In all brains, N1 was the largest nigrosome, followed by N2 and N4. The smallest nigrosomes were N3 and N5, with not significantly different DN counts. The order of nigrosome volumes matched the order of the respective DN counts, corroborating the high correspondence between Damier et al.’s nigrosome delineation and ours.
Fig. 3: Nigrosome R2* rates in 3 post mortem brains. A: Substantia nigra (SN) showed increased R2* values. In SN, we observed a stripe of increased R2*. B: Nigrosome segmentations on A. The stripe in A corresponded to nigrosome 1 (N1). C: Nigrosome R2* ranged from 55s⁻¹ to 75s⁻¹. Error bars show standard deviations over the three evaluated brains. D: Compared to the surrounding, we found significantly increased R2* for all brains in N1 (at least p<10⁻⁸ in Student t-test), N2 (p<10⁻⁹), and N4 (p<10⁻³). For the small N3 and N5, inconsistent differences may indicate inaccurate registration.